Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection
- PMID: 15716561
- DOI: 10.1056/NEJMoa041681
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection
Abstract
Background: Many sex partners of persons with gonorrhea or chlamydial infections are not treated, which leads to frequent reinfections and further transmission.
Methods: We randomly assigned women and heterosexual men with gonorrhea or chlamydial infection to have their partners receive expedited treatment or standard referral. Patients in the expedited-treatment group were offered medication to give to their sex partners, or if they preferred, study staff members contacted partners and provided them with medication without a clinical examination. Patients assigned to standard partner referral were advised to refer their partners for treatment and were offered assistance notifying partners. The primary outcome was persistent or recurrent gonorrhea or chlamydial infection in patients 3 to 19 weeks after treatment.
Results: Persistent or recurrent gonorrhea or chlamydial infection occurred in 121 of 931 patients (13 percent) assigned to standard partner referral and 92 of 929 (10 percent) assigned to expedited treatment of sexual partners (relative risk, 0.76; 95 percent confidence interval, 0.59 to 0.98). Expedited treatment was more effective than standard referral of partners in reducing persistent or recurrent infection among patients with gonorrhea (3 percent vs. 11 percent, P=0.01) than in those with chlamydial infection (11 percent vs. 13 percent, P=0.17) (P=0.05 for the comparison of treatment effects) and remained independently associated with a reduced risk of persistent or recurrent infection after adjustment for other predictors of infection at follow-up (relative risk, 0.75; 95 percent confidence interval, 0.57 to 0.97). Patients assigned to expedited treatment of sexual partners were significantly more likely than those assigned to standard referral of partners to report that all of their partners were treated and significantly less likely to report having sex with an untreated partner.
Conclusions: Expedited treatment of sex partners reduces the rates of persistent or recurrent gonorrhea or chlamydial infection.
Copyright 2005 Massachusetts Medical Society.
Comment in
-
Toward better control of sexually transmitted diseases.N Engl J Med. 2005 Feb 17;352(7):720-1. doi: 10.1056/NEJMe048321. N Engl J Med. 2005. PMID: 15716568 No abstract available.
-
Expedited treatment of sex partners.N Engl J Med. 2005 May 12;352(19):2026-7; author reply 2026-7. doi: 10.1056/NEJM200505123521920. N Engl J Med. 2005. PMID: 15888708 No abstract available.
Similar articles
-
Expedited partner therapy: a robust intervention.Sex Transm Dis. 2010 Oct;37(10):602-7. doi: 10.1097/OLQ.0b013e3181e1a296. Sex Transm Dis. 2010. PMID: 20601929 Clinical Trial.
-
Expedited partner therapy for adolescents diagnosed with gonorrhea or chlamydia: a review and commentary.Adolesc Med Clin. 2006 Oct;17(3):687-95; abstract xii. doi: 10.1016/j.admecli.2006.06.005. Adolesc Med Clin. 2006. PMID: 17030286 Review.
-
Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.Clin Infect Dis. 2005 Sep 1;41(5):623-9. doi: 10.1086/432476. Epub 2005 Jul 19. Clin Infect Dis. 2005. PMID: 16080084 Clinical Trial.
-
Expedited treatment for partners of patients with gonorrhea and/or chlamydial infection: impact on rates of persistence or recurrence.Postgrad Med. 2005 May;117(5):6. doi: 10.3810/pgm.2005.05.1634. Postgrad Med. 2005. PMID: 15948359 No abstract available.
-
Issues in the management of sexually transmitted diseases in Papua New Guinea.P N G Med J. 1996 Sep;39(3):252-60. P N G Med J. 1996. PMID: 9795576 Review.
Cited by
-
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia.Antibiotics (Basel). 2024 May 4;13(5):421. doi: 10.3390/antibiotics13050421. Antibiotics (Basel). 2024. PMID: 38786149 Free PMC article.
-
The Management of Gonorrhea in the Era of Emerging Antimicrobial Resistance: What Primary Care Clinicians Should Know.Med Clin North Am. 2024 Mar;108(2):279-296. doi: 10.1016/j.mcna.2023.08.015. Epub 2023 Sep 14. Med Clin North Am. 2024. PMID: 38331480 Review.
-
Sexually Transmitted Infection Prevention Perspectives in Black Men Who Have Sex With Men Taking Preexposure Prophylaxis in New Orleans.Sex Transm Dis. 2024 Feb 1;51(2):90-95. doi: 10.1097/OLQ.0000000000001908. Epub 2023 Dec 11. Sex Transm Dis. 2024. PMID: 38100815 Free PMC article.
-
Implementation preferences for the management of sexually transmitted infections in the South African health system: a discrete choice experiment.Sex Transm Infect. 2024 Jan 17;100(1):10-16. doi: 10.1136/sextrans-2023-055816. Sex Transm Infect. 2024. PMID: 37918916 Free PMC article.
-
Mixed-methods Evaluation of an Expedited Partner Therapy Take-home Medication Program: Pilot Emergency Department Intervention to Improve Sexual Health Equity.West J Emerg Med. 2023 Sep;24(5):993-1004. doi: 10.5811/westjem.59506. West J Emerg Med. 2023. PMID: 37788042 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical